Published Date : 2025-Apr-09
Smart Pills Technology – ingestible medical devices embedded with sensors – are revolutionizing healthcare. From improving medication adherence to offering real-time diagnostic capabilities, this tech is reshaping remote patient monitoring, GI diagnostics, and chronic disease management. By 2034, the global smart pills market is poised to exceed $10.9 billion, driven by innovation across major pharmaceutical, med-tech, and digital health giants.
Here are the Top trailblazers in this space: Medtronic, CapsoVision, Philips, Olympus Corporation, Bio-Images Research Limited (BIRL), Novartis AG, Check-Cap Ltd. And More.
Overview: Medtronic is a global leader in medical technology, recognized for its contributions to smart pill technologies, especially through its PillCam capsule endoscopy platform, which it acquired via Given Imaging in 2014. The PillCam provides non-invasive imaging of the gastrointestinal (GI) tract and is widely used for diagnosing GI bleeding, Crohn’s disease, and colon cancer.
A leader in smart pill technology through its Ingestible Sensor Platform and PillCam (via Given Imaging). Also enhanced by its acquisition of Mazor Robotics. Focuses on patient adherence, vital sign monitoring, and digital diagnostics.
Overview: CapsoVision is a California-based medical device company focused on developing advanced capsule endoscopy systems for gastrointestinal (GI) diagnostics. Its flagship product, the CapsoCam Plus®, offers 360-degree panoramic imaging, setting it apart from traditional smart pill cameras.
Unlike other capsule endoscopy systems that rely on real-time data transfer to external belts or receivers, CapsoVision's technology stores data internally, enhancing patient comfort and mobility.
Overview: Koninklijke Philips N.V., known globally as Philips, is a Dutch multinational conglomerate leading innovations in healthcare technology, including smart pills through its subsidiary Medimetrics. Philips leverages its expertise in sensor systems, AI, and telehealth to develop ingestible devices that monitor patient data and medication adherence.
Its commitment to connected care and precision diagnostics has made Philips a prominent name in the remote health monitoring and personalized medicine markets.
Overview: Olympus Corporation is a renowned Japanese manufacturer with a legacy in optics, imaging, and medical technology, particularly known for its diagnostic endoscopy systems. In the smart pills sector, Olympus made significant contributions through its EndoCapsule – an ingestible capsule designed to perform non-invasive GI tract visualization.
Olympus combines traditional optics excellence with smart, minimally invasive medical innovations to address the diagnostic challenges of gastrointestinal diseases like bleeding, Crohn’s disease, polyps, and cancers.
Overview: Bio-Images Research Limited (BIRL), part of BDD Pharma Ltd, is a UK-based clinical research organization specializing in oral drug delivery, ingestible sensors, and real-time gastrointestinal (GI) tracking. The company is at the forefront of smart pill technologies that combine pharmaceutical formulation with radiolabeling and imaging capabilities to track drug release inside the human body.
Its work supports pharmaceutical R&D, enabling detailed in vivo studies that improve drug efficacy, compliance, and targeted delivery.
Overview: Novartis AG is a global pharmaceutical giant known for its deep investments in digital health, smart therapeutics, and precision medicine. Within the smart pills sector, Novartis pioneered the first FDA-approved digital medicine — in collaboration with Proteus Digital Health — to monitor medication adherence in real time.
Novartis sees ingestible sensors and digital feedback loops as vital to improving drug outcomes, especially for chronic disease and psychiatric patients.
Partnered with Proteus to launch the Halo System, combining sensors with meds to track dosage adherence and real-time health data.
Overview: Check-Cap Ltd. is an Israel-based clinical-stage medical diagnostics company developing the world’s first ingestible imaging capsule for colorectal cancer (CRC) screening without the need for bowel preparation or sedation. Their flagship product, C-Scan®, offers a non-invasive alternative to colonoscopy, using low-dose X-ray and advanced computation to scan the colon from within as it passes through the gastrointestinal (GI) tract.
By replacing traditional colonoscopy with a patient-friendly capsule-based solution, Check-Cap is addressing a major global challenge in CRC early detection: low compliance rates due to the invasive nature of standard screening.
Region | Key Drivers | Forecast Share (%) |
North America | Tech innovation, FDA approvals, chronic disease management | 38% |
Europe | Aging population, early adoption in diagnostics | 26% |
Asia-Pacific | Rising healthcare investment, aging populations | 20%+ |
Latin America & MEA | Emerging markets, limited penetration | <10% |
Smart pill technology is at the intersection of digital health, AI diagnostics, and biopharmaceutical delivery systems. With major players pushing innovation in ingestible sensors, capsule endoscopy, and real-time health tracking, the smart pills market is poised for exponential growth by 2025.
These ten companies are shaping the future of precision medicine, one capsule at a time.
Would you like me to add more details on specific companies or market trends? Let me know! CLICK HERE
Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.
